SAN DIEGO--(BUSINESS WIRE)-- The Centre Antoine-Lacassagne Cancer Center (CAL), in Nice, France, has signed a letter of intent with IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg ...
IBA (Ion Beam Applications SA), the global leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer and Heidelberg University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback